KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Interest & Investment Income: 2010-2017

Historic Interest & Investment Income for Emergent BioSolutions (EBS) over the last 8 years, with Dec 2017 value amounting to $1.8 million.

  • Emergent BioSolutions' Interest & Investment Income rose 10.05% to $701,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.4 million, marking a year-over-year decrease of 26.20%. This contributed to the annual value of $1.8 million for FY2017, which is 66.48% up from last year.
  • As of FY2017, Emergent BioSolutions' Interest & Investment Income stood at $1.8 million, which was up 66.48% from $1.1 million recorded in FY2016.
  • Emergent BioSolutions' 5-year Interest & Investment Income high stood at $1.8 million for FY2017, and its period low was $139,000 during FY2013.
  • In the last 3 years, Emergent BioSolutions' Interest & Investment Income had a median value of $1.1 million in 2016 and averaged $1.1 million.
  • Data for Emergent BioSolutions' Interest & Investment Income shows a peak YoY skyrocketed of 130.22% (in 2014) over the last 5 years.
  • Over the past 5 years, Emergent BioSolutions' Interest & Investment Income (Yearly) stood at $139,000 in 2013, then surged by 130.22% to $320,000 in 2014, then surged by 78.75% to $572,000 in 2015, then skyrocketed by 84.09% to $1.1 million in 2016, then skyrocketed by 66.48% to $1.8 million in 2017.